Telehealth · IN
Indiana.
Licensed by the Medical Licensing Board of Indiana
Indiana residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — from Indianapolis and Fort Wayne to Evansville, South Bend, and the rural counties in between. Pallas Health pairs you with a board-certified provider licensed in Indiana who reviews your intake — by secure message in most cases — and, if appropriate, sends a prescription to a compounding pharmacy that ships to any Indiana address in 2–3 business days.
Telehealth
Async + video
Asynchronous review permitted
Compounded sema
Available
Compounded tirz
Available
Shipping
2–3 business days
To any Indiana address
Regulatory
How telehealth prescribing works in Indiana
Indiana permits licensed providers to establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth — including asynchronous review of your intake — when the standard of care is met.
Indiana requires any provider prescribing to an Indiana resident to hold an active Indiana medical license — an out-of-state license is not sufficient. Under Indiana's telehealth statute (IC 25-1-9.5) and Medical Licensing Board of Indiana rules, a licensed provider may use telehealth to establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s, including synchronous video and, in appropriate cases, asynchronous review, provided the standard of care is met and the encounter is properly documented. Every Pallas provider who treats Indiana patients holds an active Indiana medical license. GLP-1s are not controlled substances, so Indiana's separate controlled-substance telemedicine requirements do not apply — but our providers still take a complete history, screen for contraindications like personal or family history of medullary thyroid carcinoma, and follow up after initiation to monitor response and titrate the dose.
Insurance
Medicaid & insurance in Indiana
Limited coverage
Indiana Medicaid, including the Healthy Indiana Plan (HIP), covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited, and compounded GLP-1s are not covered.
Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.
Coverage
Cities served in Indiana
We ship to every ZIP code in Indiana, including:
- Indianapolis
- Fort Wayne
- Evansville
- South Bend
- Carmel
- Fishers
- Bloomington
- Hammond
FAQ
Indiana GLP-1 questions
Usually no. Indiana allows a licensed provider to establish the provider-patient relationship and prescribe non-controlled medications like semaglutide through telehealth, including asynchronous review of your intake. Most Indiana patients complete everything by secure message; a provider may request a brief video visit only if your history calls for it.
Yes. Compounded semaglutide prescribed by an Indiana-licensed provider and dispensed by a licensed compounding pharmacy is legal when prepared for an individual patient with a documented clinical need. Pallas works only with U.S. state-licensed 503A and 503B compounding pharmacies.
Indiana Medicaid, including the Healthy Indiana Plan, covers GLP-1s for type 2 diabetes with prior authorization. Weight-management coverage is limited, and compounded GLP-1s are not covered. Pallas is a cash-pay service, so Medicaid rules do not apply to our prescriptions.
Most Indiana patients receive their medication within 2–3 business days of the pharmacy filling the prescription. Indianapolis, Fort Wayne, and other metros typically ship fastest; rural addresses may take an extra day.
Start your Indiana intake